1101895

Tesaro a GSK Company — FEI 3009154441

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 16, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Waltham, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)